DR. GORDON BRANDT, MD
Osteopathic Medicine at Kalmia Ct, Bellevue, WA
License number
Washington A54864
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
790 Kalmia Ct NW, Bellevue, WA 98027
Phone
(425) 301-9929
Personal information
See more information about GORDON BRANDT at radaris.comName
Address
Phone
790 Kalmia Ct NW, Issaquah, WA 98027
Wenatchee, WA
Professional information
See more information about GORDON BRANDT at trustoria.com
Gordon C Brandt, Issaquah WA
Gordon C Brandt, Issaquah WA
Specialties:
Internal Medicine
Address:
790 Kalmia Ct NW, Issaquah 98027
Languages:
English
Education:
Medical School
University of California At San Francisco
Graduated: 1994
University of California At San Francisco
Graduated: 1994
Compositions And Methods For Enhanced Mucosal Delivery And Non-Infused Administration Of Y2 Receptor-Binding Peptides And Methods For Treating And Preventing Obesity
Compositions And Methods For Enhanced Mucosal Delivery And Non-Infused Administration Of Y2 Receptor-Binding Peptides And Methods For Treating And Preventing Obesity
US Patent:
7186692, Mar 6, 2007
Filed:
Jun 16, 2004
Appl. No.:
10/869649
Inventors:
Steven C. Quay - Edmonds WA, US
Gordon Brandt - Issaquah WA, US
Gordon Brandt - Issaquah WA, US
Assignee:
Nastech Pharmaceutical Company Inc. - Bothell WA
International Classification:
A61K 38/17, A61K 38/28, C07K 14/435
US Classification:
514 12, 530324, 530303
Abstract:
Pharmaceutical compositions and methods are described comprising at least one Y2 receptor-binding peptide, such as peptide YY(PYY), Neuropeptide Y (NPY) or Pancreatic Peptide (PP) and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of the peptide YY, for treating a variety of diseases and conditions in mammalian subjects, including obesity.
A Device For Enhanced Epithelial Permeation Of Y2 Receptor-Binding Peptides
A Device For Enhanced Epithelial Permeation Of Y2 Receptor-Binding Peptides
US Patent:
2007016, Jul 12, 2007
Filed:
Nov 22, 2006
Appl. No.:
11/562913
Inventors:
Steven Quay - Woodinville WA, US
Gordon Brandt - Issaquah WA, US
Mary Kleppe - Snohomish WA, US
Conor MacEvilly - Seattle WA, US
Gordon Brandt - Issaquah WA, US
Mary Kleppe - Snohomish WA, US
Conor MacEvilly - Seattle WA, US
International Classification:
A61K 38/22, A61K 31/70, A61K 31/7012, A61K 31/715, A61K 31/045, A61K 31/724
US Classification:
514012000, 514054000, 514058000, 514023000, 514061000, 514053000, 604500000, 514738000
Abstract:
A pharmaceutical device comprising a composition comprising an aqueous solution of PYY(3-36), a cyclodextrin, and a compound selected from phosphatidylcholine or diglyceride, wherein the cyclodextrin and the compound selected from phosphatidylcholine or diglyceride are present in an amount sufficient to enhance epithelial permeation, and wherein the composition is present in a container; and an actuator fluidly connected to the container, wherein the actuator has a tip which defines a passage through which the solution is ejected to produce a spray of the solution.
Method Of Treating Osteoporosis Using Intranasal Parathyroid Hormone
Method Of Treating Osteoporosis Using Intranasal Parathyroid Hormone
US Patent:
2006005, Mar 9, 2006
Filed:
Oct 6, 2005
Appl. No.:
11/246406
Inventors:
Steven Quay - Seattle WA, US
Gordon Brandt - Issaquah WA, US
Henry Costantino - Woodinville WA, US
Gordon Brandt - Issaquah WA, US
Henry Costantino - Woodinville WA, US
International Classification:
A61K 38/29, A61K 31/195
US Classification:
514012000, 514566000
Abstract:
What is described is a method for treating osteoporosis in a mammal comprising administering intranasally a therapeutically effective amount of a PTH formulation to the mammal wherein the PTH formulation is an aqueous formulation comprised of a PTH peptide and one or more excipients selected from the group consisting of a water-miscible polar organic solvent, a surface active agent, and a chelating agent for cations.
Compositions And Methods For Enhanced Mucosal Delivery Of Y2 Receptor-Binding Peptides And Methods For Treating And Preventing Obesity
Compositions And Methods For Enhanced Mucosal Delivery Of Y2 Receptor-Binding Peptides And Methods For Treating And Preventing Obesity
US Patent:
7229966, Jun 12, 2007
Filed:
Feb 17, 2004
Appl. No.:
10/780325
Inventors:
Steven C. Quay - Edmonds WA, US
Gordon Brandt - Issaquah WA, US
Mary S. Kleppe - Kingston WA, US
Conor J. MacEvilly - Seattle WA, US
Gordon Brandt - Issaquah WA, US
Mary S. Kleppe - Kingston WA, US
Conor J. MacEvilly - Seattle WA, US
Assignee:
Nastech Pharmaceutical Company Inc. - Bothell WA
International Classification:
A61K 38/17, A61K 38/28, C07K 14/435, B05B 11/02
US Classification:
514 12, 530324, 530303, 222631
Abstract:
Pharmaceutical compositions and methods are described comprising at least one Y2 receptor-binding peptide, such as peptide YY(PYY), Neuropeptide Y (NPY) or Pancreatic Peptide (PP) and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of the peptide YY, for treating a variety of diseases and conditions in mammalian subjects, including obesity.
Compositions And Methods For Enhanced Mucosal Delivery Of Y2 Receptor-Binding Peptides And Methods For Treating And Preventing Obesity
Compositions And Methods For Enhanced Mucosal Delivery Of Y2 Receptor-Binding Peptides And Methods For Treating And Preventing Obesity
US Patent:
7186691, Mar 6, 2007
Filed:
Dec 23, 2003
Appl. No.:
10/745069
Inventors:
Steven C. Quay - Edmonds WA, US
Gordon Brandt - Issaquah WA, US
Mary S. Kleppe - Kingston WA, US
Conor J. MacEvilly - Seattle WA, US
Gordon Brandt - Issaquah WA, US
Mary S. Kleppe - Kingston WA, US
Conor J. MacEvilly - Seattle WA, US
Assignee:
Nastech Pharmaceutical Company Inc. - Rothell WA
International Classification:
A61K 38/17, A61K 38/28, C07K 14/435
US Classification:
514 12, 530324, 530303
Abstract:
Pharmaceutical compositions and methods are described comprising at least one Y2 receptor-binding peptide, such as peptide YY(PYY), Neuropeptide Y (NPY) or Pancreatic Peptide (PP) and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of the peptide YY, for treating a variety of diseases and conditions in mammalian subjects, including obesity.
Compositions And Methods For Enhanced Mucosal Delivery Of Y2 Receptor-Binding Peptides And Methods For Treating And Preventing Obesity
Compositions And Methods For Enhanced Mucosal Delivery Of Y2 Receptor-Binding Peptides And Methods For Treating And Preventing Obesity
US Patent:
7157426, Jan 2, 2007
Filed:
Jan 30, 2004
Appl. No.:
10/768288
Inventors:
Steven C. Quay - Edmonds WA, US
Gordon Brandt - Issaquah WA, US
Mary S. Kleppe - Kingston WA, US
Conor J. MacEvilly - Seattle WA, US
Gordon Brandt - Issaquah WA, US
Mary S. Kleppe - Kingston WA, US
Conor J. MacEvilly - Seattle WA, US
Assignee:
Nastech Pharmaceutical Company Inc. - Bothell WA
International Classification:
A61K 38/17, A61K 9/10, A61K 38/22, A61L 9/14, C07K 14/435
US Classification:
514 12, 424 45, 424450, 530324, 530399
Abstract:
Pharmaceutical compositions and methods are described comprising at least one Y2 receptor-binding peptide, such as peptide YY(PYY), Neuropeptide Y (NPY) or Pancreatic Peptide (PP) and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of the peptide YY, for treating a variety of diseases and conditions in mammalian subjects, including obesity.
Compositions For Enhanced Epithelial Permeation Of Y2 Receptor-Binding Peptides
Compositions For Enhanced Epithelial Permeation Of Y2 Receptor-Binding Peptides
US Patent:
2007019, Aug 23, 2007
Filed:
Nov 20, 2006
Appl. No.:
11/561825
Inventors:
Steven Quay - Woodinville WA, US
Gordon Brandt - Issaquah WA, US
Mary Kleppe - Snohomish WA, US
Conor MacEvilly - Seattle WA, US
Gordon Brandt - Issaquah WA, US
Mary Kleppe - Snohomish WA, US
Conor MacEvilly - Seattle WA, US
International Classification:
A61K 38/22, A61K 31/724
US Classification:
514012000, 514058000
Abstract:
Pharmaceutical compositions comprising a PYY peptide, a cyclodextrin, and a compound selected from phosphatidylcholine or diglyceride, wherein the cyclodextrin and the compound selected from phosphatidylcholine or diglyceride are present in an amount sufficient to enhance epithelial permeation.
Methods For Enhanced Epithelial Permeation Of Y2 Receptor-Binding Peptides For Treating And Preventing Obesity
Methods For Enhanced Epithelial Permeation Of Y2 Receptor-Binding Peptides For Treating And Preventing Obesity
US Patent:
2008000, Jan 3, 2008
Filed:
Nov 27, 2006
Appl. No.:
11/563587
Inventors:
Steven Quay - Woodinville WA, US
Gordon Brandt - Issaquah WA, US
Gordon Brandt - Issaquah WA, US
International Classification:
A61K 38/17, A61P 3/04
US Classification:
514012000
Abstract:
A method for treating obesity, inducing weight-loss, or inducing satiety in a mammal comprising administering intranasally to the mammal a therapeutically effective amount of a pharmaceutical composition comprising PYY(3-36), a phosphatidylcholine or diglyceride, and a cyclodextrin, wherein the phosphatidylcholine or diglyceride and the cyclodextrin are present in an amount sufficient to enhance epithelial permeation.
Compositions And Methods For Enhanced Mucosal Delivery Of Pyy Peptide
Compositions And Methods For Enhanced Mucosal Delivery Of Pyy Peptide
US Patent:
2007012, Jun 7, 2007
Filed:
Aug 25, 2006
Appl. No.:
11/467509
Inventors:
Steven Quay - Seattle WA, US
Gordon Brandt - Issaquah WA, US
Mary Kleppe - Snohomish WA, US
Conor MacEvilly - Seattle WA, US
Gordon Brandt - Issaquah WA, US
Mary Kleppe - Snohomish WA, US
Conor MacEvilly - Seattle WA, US
International Classification:
A61K 38/22, A61K 31/724
US Classification:
514012000, 514058000
Abstract:
Pharmaceutical compositions are described comprising PYY(3-36) (SEQ ID NO: 2), a solubilizing agent, a lipid, a polyol.